|
|
 |
MESSAGE |
|
Year : 2012 | Volume
: 4
| Issue : 5 | Page : 0 |
|
|
Message
Akshai Aggarwal
Vice Chancellor, Gujarat Technological University, 2nd Floor, ACPC Building, L. D. College of Engineering Campus, Navrangpura, Ahmedabad, (Gujarat) 380015, India
Date of Web Publication | 21-Mar-2012 |
Correspondence Address: Akshai Aggarwal Vice Chancellor, Gujarat Technological University, 2nd Floor, ACPC Building, L. D. College of Engineering Campus, Navrangpura, Ahmedabad, (Gujarat) 380015 India
 Source of Support: None, Conflict of Interest: None  | Check |

How to cite this article: Aggarwal A. Message. J Pharm Bioall Sci 2012;4, Suppl S1:0 |
The Indian pharmaceutical sector has come a long way from being an almost non-existent industry before 1970 to a prominent provider of healthcare products now, meeting almost 95 per cent of the, country's pharma needs. The industry today is in the forefront of India's science-based industries, with wide ranging capabilities in the complex field of drug manufacturing and technology.
The drug delivery technology landscape is highly competitive and rapidly evolving. Improved methods for the development, manufacture, and administration of drugs are more in demand than ever and are being met with advanced drug delivery options. Expansion of biologics in the marketplace has fostered the exploration of drug delivery methods. With fewer new drugs coming to market, pharmaceutical companies increasingly look to hold onto product revenues of existing drugs through new drug delivery options, reformulations and product line extensions, aimed at improving safety, efficacy, patient compliance and ease of use. While many approaches exist to 'lifecycle manage' a product, those pursued using drug delivery approaches have proven more effective than most, particularly where patient/clinical benefits are apparent
It is the responsibility of the pharma professionals from various fields like industry, academics, hospitals, marketing etc. to work together for making the health care service more efficient and cost effective and for bringing optimum benefit to the patients. Increasing the interaction between the professionals working in the industry and academic researchers for drug discovery and development will spruce up the process and will cut timelines to market and reduce costs associated with drug discovery and development.
Gujarat Technological University has organized the national conference in collaboration with Baroda College of Pharmacy and Parul Institute of Pharmacy. The objective of the conference is to bring together professionals working in the Pharmaceutical industries and academic researchers in the area of New Drug Delivery Technologies, thereby facilitating interaction between such professionals. This may facilitate mutual understanding of each other's strengths and challenges. A number of learned speakers both from the industry and RandD organizations and renowned academic institutions have been invited to deliver plenary talks at the conference. We expect these talks to authoritatively delineate the developments in their respective fields.
I hope this conference will bring new momentum to research and development of new technologies for effective, safe and efficient delivery of drugs at GTU, other Universities as well as at the industrial research laboratories.
|